Under Pressure From Opioid Lawsuits, One Pain Research Society Considers Bankruptcy
The enormous opioid lawsuits across the nation are affecting pain science too.
Should We Blame Pharmaceutical Companies for America's Opioid Epidemic? Here's What the Science Says.
Legal evidence is needed to pin addiction and death on opioid manufacturers, but the science suggests that a large and ready supply of legal prescription painkillers led to many addictions.
Generic Drug Prices Are Dropping, but Who Is This Really Benefiting?
It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs.
Corporate Incentives Make Insurers Favor Pushing Brand-Name Drugs Over Cheaper Generics
Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics.
Behind Pharmaceutical Companies' Money-Back Guarantees
Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected.
FDA Asks Drug Company to Stop Selling Easy-to-Abuse Painkiller
Endo Pharmaceuticals appears to be preparing its opposition to the FDA's request.
Biotech Leaders Say Quit Whining About Drug Prices
But the people won't, as the push for pharma reform mounts.
Big Pharma Is Keeping Us From Developing Low-Cost Cancer Treatments
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."